Technology News and Research

RSS

Cellectricon awards Cellaxess ACE project grant to support research in cell biology

Cellectricon, a leading provider of advanced cell-based screening technologies and services, has announced the two winners of its Cellaxess ACE project grant, supporting cutting-edge research in cell biology.

From Cellectricon 21 Sep 2013

MRE imaging technique accurately detects chronic liver disease in children

A new, non-invasive imaging technique, magnetic resonance elastography (MRE), can now help physicians accurately detect fibrosis (scarring) in children with chronic liver disease - a growing problem due in part to increasing obesity rates.

21 Sep 2013

Virginia Tech to receive NIH grant to propel contributions in biomedical research

Virginia Tech has been named one of 10 academic institutions to receive a first-of-its-kind grant from the National Institutes of Health to help prepare graduate students and postdoctoral scholars for biomedical research careers that could take them beyond conventional academic research.

21 Sep 2013

BASF Eyes Strategic Protein Growth, Buys Verenium For $62M

...

20 Sep 2013

UH Seidman Cancer Center to become one of elite group of cancer centers to offer proton therapy

University Hospitals Seidman Cancer Center is breaking ground today on a $30 million proton therapy center, becoming one of an elite group of cancer centers in the country to offer this revolutionary technology. There are currently only 11 operational proton therapy centers in the nation and the UH Seidman Cancer Center site will be the first in Ohio.

20 Sep 2013

Vera and Paul Guerin Family Congenital Heart Program to be established in Cedars-Sinai Heart Institute

In an effort to lengthen the life span and improve the quality of life for those born with heart defects, longtime Cedars-Sinai supporters Vera and Paul Guerin have donated $10 million to establish the Vera and Paul Guerin Family Congenital Heart Program in the Cedars-Sinai Heart Institute.

20 Sep 2013

Genetics in Medicine's October 2013 issue details solutions for integrating genomic data into EHR

Genetic tests can now tell us whether we are at increased risk of various cancers, heart or kidney disease, asthma and a number of other conditions.

20 Sep 2013

Brain exposed to social media browsing can easily become hobbled by information overload

While you are browsing online, you could be squandering memories - or losing important information. Contrary to common wisdom, an idle brain is in fact doing important work - and in the age of constant information overload, it's a good idea to go offline on a regular basis, says a researcher from Stockholm's KTH Royal Institute of Technology.

20 Sep 2013

LCT successfully implants first patient with potential Parkinson's disease treatment

Living Cell Technologies Limited today announced that the first patient has been successfully implanted in the Phase I clinical trial of the regenerative cell therapy NTCELL – a potential treatment for Parkinson's disease.

20 Sep 2013

Visual clue to schizophrenia pathology

Researchers say that retinal imaging could be a useful tool for studying some of the pathologic processes associated with schizophrenia.

19 Sep 2013

Google Eyes Wider Healthcare Footprint With Tech-Focused Calico

...

19 Sep 2013

Agilent Marries Life-Sci And Diagnostics, On Eve Of Measurement Spinout

...

19 Sep 2013

Orbeshield Earns Soligenix Up To $26.3M From BARDA

...

19 Sep 2013

Florida Hospital To Evaluate VTT’S Alzheimer’S Biomarker Assay

VTT Technical Research Centre of Finland is taking an important step toward advancing its Alzheimer's disease biomarker by collaborating with the Florida Hospital Neuroscience Institute to evaluate screening, diagnostic, and prognostic potential of the biomarker assay and utilize it to specifically target which types of precautions to take when approaching early stages of the disease.

19 Sep 2013

World’s first preclinical Magnetic Particle Imaging (MPI) system announced by Bruker

At the 2013 World Molecular Imaging Congress (WMIC, www.wmicmeeting.org), Bruker today announced the world’s first Magnetic Particle Imaging (MPI) system, an entirely new technology for preclinical imaging. The addition of MPI as a complementary preclinical imaging technique for disease studies, translational research and drug discovery, has significant potential in helping researchers gain new insights into disease processes at the organ, cellular and molecular level.

From Bruker BioSpin Group 19 Sep 2013

BARDA Exercises $6M Option For Aeolus' Acute Radiation Syndrome Drug

...

19 Sep 2013

GSK Returns Vercirnon Rights To Chemocentryx After Phase III Flop

...

19 Sep 2013

ParaVision® 6 software from Bruker introduced at 2013 World Molecular Imaging Congress

At the 2013 World Molecular Imaging Congress (WMIC, www.wmicmeeting.org), Bruker today introduces its ParaVision® 6 software, setting new standards in preclinical MRI software that delivers significantly enhanced productivity for both, routine users and accomplished experts. A redefined workflow introduces optimized, application-oriented experimental protocols, an intuitive, interactive 3D scan planning viewport, and automatic reporting. Thanks to its DICOM-based data exchange module, ParaVision 6 seamlessly integrates with data from multimodal imaging studies employed in many preclinical research labs.

From Bruker BioSpin Group 19 Sep 2013

Novel paper-clip sized device used to tackle resistant high blood pressure

Researchers at the University of Leicester and Glenfield Hospital have successfully used a novel "paper-clip" sized vascular coupling device to tackle resistant high blood pressure.

19 Sep 2013

arGEN-X and Shire achieve milestone in SIMPLE Antibody R&D collaboration

arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has attained a key success milestone in its SIMPLE Antibody research and product development collaboration with the Human Genetic Therapies division of Shire Pharmaceuticals. The milestone, which triggered an undisclosed payment from Shire, was the first demonstration of in vivo proof of concept for one of the antibody discovery programs undertaken in the collaboration.

19 Sep 2013

Technology News and Research

Cellectricon awards Cellaxess ACE project grant to support research in cell biology

MRE imaging technique accurately detects chronic liver disease in children

Virginia Tech to receive NIH grant to propel contributions in biomedical research

BASF Eyes Strategic Protein Growth, Buys Verenium For $62M

UH Seidman Cancer Center to become one of elite group of cancer centers to offer proton therapy

Vera and Paul Guerin Family Congenital Heart Program to be established in Cedars-Sinai Heart Institute

Genetics in Medicine's October 2013 issue details solutions for integrating genomic data into EHR

Brain exposed to social media browsing can easily become hobbled by information overload

LCT successfully implants first patient with potential Parkinson's disease treatment

Visual clue to schizophrenia pathology

Google Eyes Wider Healthcare Footprint With Tech-Focused Calico

Agilent Marries Life-Sci And Diagnostics, On Eve Of Measurement Spinout

Orbeshield Earns Soligenix Up To $26.3M From BARDA

Florida Hospital To Evaluate VTT’S Alzheimer’S Biomarker Assay

World’s first preclinical Magnetic Particle Imaging (MPI) system announced by Bruker

BARDA Exercises $6M Option For Aeolus' Acute Radiation Syndrome Drug

GSK Returns Vercirnon Rights To Chemocentryx After Phase III Flop

ParaVision® 6 software from Bruker introduced at 2013 World Molecular Imaging Congress

Novel paper-clip sized device used to tackle resistant high blood pressure

arGEN-X and Shire achieve milestone in SIMPLE Antibody R&D collaboration

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News